Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes
- PMID: 9030614
- PMCID: PMC6573369
- DOI: 10.1523/JNEUROSCI.17-05-01539.1997
Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes
Abstract
Fragile X syndrome, a leading cause of inherited mental retardation, is attributable to the unstable expansion of a CGG-repeat within the FMR1 gene that results in the absence of the encoded protein. The fragile X mental retardation protein (FMRP) is a ribosome-associated RNA-binding protein of uncertain function that contains nuclear localization and export signals. We show here detailed cellular localization studies using both biochemical and immunocytochemical approaches. FMRP was highly expressed in neurons but not glia throughout the rat brain, as detected by light microscopy. Although certain structures, such as hippocampus, revealed a strong signal, the regional variation in staining intensity appeared to be related to neuron size and density. In human cell lines and mouse brain, FMRP co-fractionated primarily with polysomes and rough endoplasmic reticulum. Ultrastructural studies in rat brain revealed high levels of FMRP immunoreactivity in neuronal perikarya, where it is concentrated in regions rich in ribosomes, particularly near or between rough endoplasmic reticulum cisternae. Immunogold studies also provided evidence of nucleocytoplasmic shuttling of FMRP, which was localized in neuronal nucleoplasm and within nuclear pores. Moreover, labeling was observed in large- and small-caliber dendrites, in dendritic branch points, at the origins of spine necks, and in spine heads, all known locations of neuronal polysomes. Dendritic localization, which was confirmed by co-fractionation of FMRP with synaptosomal ribosomes, suggests a possible role of FMRP in the translation of proteins involved in dendritic structure or function and relevant for the mental retardation occurring in fragile X syndrome.
Figures
Similar articles
-
Association of FMRP with ribosomal precursor particles in the nucleolus.Biochem Biophys Res Commun. 1996 Aug 5;225(1):27-33. doi: 10.1006/bbrc.1996.1126. Biochem Biophys Res Commun. 1996. PMID: 8769090
-
NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes.Exp Cell Res. 2003 Sep 10;289(1):95-107. doi: 10.1016/s0014-4827(03)00222-2. Exp Cell Res. 2003. PMID: 12941608
-
Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.J Neurosci. 2004 Mar 17;24(11):2648-55. doi: 10.1523/JNEUROSCI.0099-04.2004. J Neurosci. 2004. PMID: 15028757 Free PMC article.
-
Molecular insights into mental retardation: multiple functions for the Fragile X mental retardation protein?Curr Issues Mol Biol. 2004 Jul;6(2):73-88. Curr Issues Mol Biol. 2004. PMID: 15119819 Review.
-
The fragile X syndrome.J Inherit Metab Dis. 1997 Jun;20(2):139-51. doi: 10.1023/a:1005392319533. J Inherit Metab Dis. 1997. PMID: 9211186 Review.
Cited by
-
Fragile X Messenger Ribonucleoprotein Protein and Its Multifunctionality: From Cytosol to Nucleolus and Back.Biomolecules. 2024 Mar 26;14(4):399. doi: 10.3390/biom14040399. Biomolecules. 2024. PMID: 38672417 Free PMC article. Review.
-
Translational modulator ISRIB alleviates synaptic and behavioral phenotypes in Fragile X syndrome.iScience. 2024 Feb 16;27(4):109259. doi: 10.1016/j.isci.2024.109259. eCollection 2024 Apr 19. iScience. 2024. PMID: 38510125 Free PMC article.
-
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.J Psychiatry Neurosci. 2024 Mar 15;49(2):E109-E125. doi: 10.1503/jpn.230112. Print 2024 Jan-Feb. J Psychiatry Neurosci. 2024. PMID: 38490647 Free PMC article. Review.
-
The intersection of sleep and synaptic translation in synaptic plasticity deficits in neurodevelopmental disorders.J Comp Physiol B. 2024 Jun;194(3):253-263. doi: 10.1007/s00360-023-01531-3. Epub 2024 Feb 24. J Comp Physiol B. 2024. PMID: 38396062 Free PMC article. Review.
-
State-of-the-art therapies for fragile X syndrome.Dev Med Child Neurol. 2024 Jul;66(7):863-871. doi: 10.1111/dmcn.15885. Epub 2024 Feb 22. Dev Med Child Neurol. 2024. PMID: 38385885 Review.
References
-
- Abitbol M, Menini C, Delezoide A-L, Rhyner T, Vekemans M, Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet. 1993;4:147–153. - PubMed
-
- Ashley C, Wilkinson K, Reines D, Warren S. FMR 1 protein: conserved RNP family domains and selective RNA binding. Science. 1993;262:563–566. - PubMed
-
- Bonfa E, Parnassa AP, Rhoads DD, Roufa DJ, Wool IG, Elkon KB. Antiribosomal S10 antibodies in humans and MRL/lpr mice with systemic lupus erythematosus. Arthritis Rheum. 1989;32:1252–1261. - PubMed
-
- Brown WT, Houck GE, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Sklower Brooks S, Jenkins EC. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. J Am Med Assoc. 1993;270:1569–1575. - PubMed
-
- Burd CG, Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science. 1994;265:615–621. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases